HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Graeme Eisenhofer Selected Research

Fadrozole

6/2017The Aldosterone Synthase Inhibitor FAD286 is Suitable for Lowering Aldosterone Levels in ZDF Rats but not in db/db Mice.
10/2016Aldosterone Synthase Inhibition Improves Glucose Tolerance in Zucker Diabetic Fatty (ZDF) Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Graeme Eisenhofer Research Topics

Disease

108Neoplasms (Cancer)
05/2022 - 03/2002
100Pheochromocytoma
05/2022 - 03/2002
60Paraganglioma (Paragangliomas)
05/2022 - 01/2003
20Neoplasm Metastasis (Metastasis)
01/2022 - 08/2006
17Hypertension (High Blood Pressure)
02/2022 - 09/2002
17Hyperaldosteronism (Conn Syndrome)
01/2022 - 09/2006
10Adenoma (Adenomas)
01/2020 - 01/2016
10Multiple Endocrine Neoplasia Type 2a (MEN 2)
05/2012 - 08/2005
8Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2019 - 07/2003
8von Hippel-Lindau Disease (von Hippel Lindau Disease)
05/2012 - 02/2005
7Hypoxia (Hypoxemia)
11/2021 - 01/2013
7Hyperplasia
01/2020 - 02/2004
7Parkinson Disease (Parkinson's Disease)
01/2019 - 11/2002
5Obesity
10/2021 - 10/2016
5Cushing Syndrome
01/2020 - 01/2016
5Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal)
08/2007 - 05/2002
4Adrenal incidentaloma
01/2022 - 08/2005
4Type 2 Diabetes Mellitus (MODY)
10/2021 - 10/2016
4Neurofibromatosis 1 (Neurofibromatosis Type I)
07/2013 - 08/2005
3Prostatic Neoplasms (Prostate Cancer)
01/2021 - 02/2011
3Neuroblastoma
01/2020 - 06/2012
3Disease Progression
08/2019 - 11/2014
3Inflammation (Inflammations)
05/2019 - 09/2009
3Hypertensive Crisis
01/2018 - 03/2008
3Heart Failure
12/2014 - 11/2002
2Adrenocortical Carcinoma
01/2022 - 02/2020
2Polycythemia (Erythrocytosis)
11/2021 - 05/2019
2Hypoglycemia (Reactive Hypoglycemia)
11/2021 - 02/2004
2Body Weight (Weight, Body)
10/2021 - 01/2019
2Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2021 - 05/2002
2Orthostatic Hypotension (Postural Hypotension)
01/2021 - 11/2002
2Essential Hypertension
01/2020 - 01/2018
2Glioma (Gliomas)
12/2019 - 06/2013
2Carcinogenesis
05/2019 - 02/2011
2Extra-Adrenal Paraganglioma (Paraganglioma, Extra Adrenal)
01/2016 - 03/2012
2Hypotension (Low Blood Pressure)
06/2014 - 07/2003
2Carcinoid Tumor (Carcinoid)
07/2012 - 08/2004

Drug/Important Bio-Agent (IBA)

82CatecholaminesIBA
05/2022 - 03/2002
31NormetanephrineIBA
01/2022 - 05/2002
28MetanephrineIBA
01/2021 - 05/2002
25Succinate Dehydrogenase (Fumarate Reductase)IBA
01/2022 - 08/2005
23Epinephrine (Adrenaline)FDA LinkGeneric
05/2022 - 06/2003
20AldosteroneIBA
12/2020 - 05/2002
19SteroidsIBA
01/2022 - 11/2002
19Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2021 - 11/2002
173-methoxytyramine (methoxytyramine)IBA
01/2022 - 04/2005
15Dopamine (Intropin)FDA LinkGeneric
04/2019 - 07/2003
13Hydrocortisone (Cortisol)FDA LinkGeneric
01/2022 - 05/2002
13Biomarkers (Surrogate Marker)IBA
01/2021 - 07/2002
9EnzymesIBA
05/2019 - 08/2006
8Proteins (Proteins, Gene)FDA Link
05/2021 - 10/2005
7Succinic Acid (Succinate)IBA
11/2021 - 07/2013
7Hormones (Hormone)IBA
11/2021 - 08/2004
73-Iodobenzylguanidine (Iobenguane)IBA
03/2019 - 09/2003
6GlucocorticoidsIBA
05/2022 - 05/2002
6Adrenergic Agents (Adrenergic Drugs)IBA
01/2022 - 08/2006
6FumaratesIBA
05/2021 - 01/2014
6Messenger RNA (mRNA)IBA
05/2019 - 10/2005
5DNA (Deoxyribonucleic Acid)IBA
01/2017 - 11/2011
4Phosphotransferases (Kinase)IBA
01/2022 - 04/2017
4Glucose (Dextrose)FDA LinkGeneric
10/2021 - 02/2004
4Insulin (Novolin)FDA Link
10/2021 - 05/2002
4CorticosteroneIBA
01/2020 - 06/2017
4Cortodoxone (11 Deoxycortisol)IBA
01/2020 - 07/2017
4Dihydroxyphenylalanine (Dopa)IBA
02/2012 - 08/2004
3Phenylethanolamine N-MethyltransferaseIBA
05/2022 - 08/2006
3Pharmaceutical PreparationsIBA
01/2022 - 06/2012
3isocitric acid (isocitrate)IBA
05/2021 - 06/2013
3Cytochrome P-450 CYP11B2 (CYP11B2)IBA
01/2019 - 01/2016
3alpha-hydroxyglutarateIBA
01/2019 - 06/2013
3Dexamethasone (Maxidex)FDA LinkGeneric
01/2018 - 03/2008
3AndrogensIBA
01/2018 - 05/2002
3Myc associated factor XIBA
11/2014 - 05/2012
3Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
02/2012 - 10/2005
2Adrenergic Receptors (Adrenergic Receptor)IBA
02/2022 - 11/2002
2EverolimusFDA Link
01/2022 - 11/2019
2AlpelisibIBA
01/2022 - 11/2019
2Lactic Acid (Lactate)FDA LinkGeneric
11/2021 - 01/2017
2Glutamine (L-Glutamine)FDA Link
11/2021 - 01/2021
2Citric Acid (Citrate)FDA LinkGeneric
11/2021 - 01/2021
2ErythropoietinFDA Link
11/2021 - 05/2019
2Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
12/2019 - 01/2019
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
05/2019 - 01/2016
2Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
04/2019 - 12/2008
2Biological ProductsIBA
03/2019 - 12/2009
2Neurotransmitter Agents (Neurotransmitter)IBA
01/2019 - 11/2002
2Somatostatin Receptors (Somatostatin Receptor)IBA
10/2018 - 01/2016
2Adrenocorticotropic Hormone (ACTH)FDA Link
01/2018 - 01/2018
2Dehydroepiandrosterone (DHEA)IBA
07/2017 - 03/2009
2FadrozoleIBA
06/2017 - 10/2016
2MethyltransferasesIBA
01/2016 - 12/2012
2Chromogranin AIBA
04/2014 - 03/2011
2Transcription Factors (Transcription Factor)IBA
01/2013 - 08/2006

Therapy/Procedure

15Therapeutics
01/2022 - 04/2007
8Adrenalectomy
08/2020 - 08/2011
3Precision Medicine
10/2019 - 01/2016
3Sympathectomy (Sympathectomies)
04/2009 - 11/2002
2Radiotherapy
01/2021 - 12/2004
2Cesarean Section (Caesarean Section)
01/2018 - 12/2014
2Aftercare (After-Treatment)
01/2016 - 11/2008